Ca2+ and Ca2+ channel antagonists in the control of human small cell lung carcinoma cell proliferation
- 15 November 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 247 (3) , 325-331
- https://doi.org/10.1016/0922-4106(93)90202-k
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- P-type calcium channels blocked by the spider toxin ω-Aga-IVANature, 1992
- Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.Journal of Clinical Investigation, 1988
- A voltage-dependent calcium current in mouse Swiss 3T3 fibroblastsPflügers Archiv - European Journal of Physiology, 1988
- Verapamil, diltiazem and nifedipine interactions with calmodulin stimulated (Ca2+ + Mg2+)-ATPaseBiochemical Pharmacology, 1988
- EGF raises cytosolic Ca2+ in A431 and Swiss 3T3 cells by a dual mechanismExperimental Cell Research, 1987
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985
- Dihydropyridine Ca2+ entry blockers selectively inhibit peak I cAMP phosphodiesteraseEuropean Journal of Pharmacology, 1983
- A fluorescent calmodulin that reports the binding of hydrophobic inhibitory ligandsBiochemical Journal, 1983
- Calmodulin and the cell cycle: Involvement in regulation of cell-cycle progressionCell, 1982
- Calcium Spike Electrogenesis and Other Electrical Activity in Continuously Cultured Small Cell Carcinoma of the LungScience, 1981